Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 4/2015

01-04-2015 | Capsule Commentary

Capsule Commentary on Vyas et al., Diet Drink Consumption and the Risk of Cardiovascular Events: A Report from the Women’s Health Initiative

Author: Cynthia Kay, MD MS

Published in: Journal of General Internal Medicine | Issue 4/2015

Login to get access

Excerpt

This study by Vyas et al. is a retrospective report on data from the Women’s Health Initiative assessing the relationship between the amount of diet soda consumed and incidence of cardiovascular disease (CVD).1 Nearly 60,000 postmenopausal women without known CVD were evaluated and followed for 6–10 years. Diet soda intake was categorized into four groups: 0–3 drinks per month, 1–4 drinks per week, 5–7 drinks per week, and 2 or more drinks per day. …
Literature
1.
Vyas A, Rubenstein L, Robinson J, Seguin RA, Vitolins MZ, et al. Diet drink consumption and the risk of cardiovascular events: a report from the women’s health initiative. JGIM. 2014. doi:10.​1007/​s11606-014-3098-0.
2.
Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes. Diabetes Care. 2010;33(11):2477–2483.CrossRefPubMedCentralPubMed
3.
De Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr. 2011;93(6):1321–1327.CrossRefPubMedCentralPubMed
Metadata
Title
Capsule Commentary on Vyas et al., Diet Drink Consumption and the Risk of Cardiovascular Events: A Report from the Women’s Health Initiative
Author
Cynthia Kay, MD MS
Publication date
01-04-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 4/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-3109-1

Other articles of this Issue 4/2015

Journal of General Internal Medicine 4/2015 Go to the issue

Improvement Happens

Improvement Happens: Team-Based Primary Care, an Interview with Stuart Pollack

Capsule Commentary

Capsule Commentary on Abbot et al., Effect of Perineal Self-Acupressure on Constipation: A Randomized Controlled Trial

Clinical Practice: Clinical Images

Got Zinc? An Exfoliative Rash in a Parenteral Nutrition-Dependent Patient

Editorial

Big Plans, Poor Execution: The Importance of Governmental Managerial Innovation to Health Care Reform

Erratum

Erratum to: Capsule commentary on Turner, et al. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results

Capsule Commentary

Capsule Commentary on Nápoles et. al, Physician Counseling on Colorectal Cancer Screening and Receipt of Screening among Latino Patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits